(28) found that the low expression of exosomal GAS5 in serum from NSCLC patients was positively associated with advanced tumor–node–metastasis (TNM) stages and larger tumor diameter than healthy controls. The gene discussed is GAS5; the disease is non-small cell lung carcinoma.